1. Academic Validation
  2. A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection

A DNA tetrahedron-based nanosuit for efficient delivery of amifostine and multi-organ radioprotection

  • Bioact Mater. 2024 May 21:39:191-205. doi: 10.1016/j.bioactmat.2024.05.017.
Yuting Yang 1 2 Jinlong Yang 3 Jianwei Zhu 4 Xingyu Chen 1 2 Li Zhou 5 Wenjuan Ma 1 2 Yunfeng Lin 1 2 6
Affiliations

Affiliations

  • 1 State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, PR China.
  • 2 Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan, 610041, PR China.
  • 3 Department of Neurosurgery of West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • 4 Department of Neurosurgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 611731, PR China.
  • 5 Histology and Imaging Platform, Core Facility of West China Hospital, Sichuan University, Chengdu, 610041, PR China.
  • 6 National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Abstract

Unnecessary exposure to ionizing radiation (IR) often causes acute and chronic oxidative damages to normal cells and organs, leading to serious physiological and even life-threatening consequences. Amifostine (AMF) is a validated radioprotectant extensively applied in radiation and chemotherapy medicine, but the short half-life limits its bioavailability and clinical applications, remaining as a great challenge to be addressed. DNA-assembled nanostructures especially the tetrahedral framework nucleic acids (tFNAs) are promising nanocarriers with preeminent biosafety, low biotoxicity, and high transport efficiency. The tFNAs also have a relative long-term maintenance for structural stability and excellent endocytosis capacity. We therefore synthesized a tFNA-based delivery system of AMF for multi-organ radioprotection (tFNAs@AMF, also termed nanosuit). By establishing the mice models of accidental total body irradiation (TBI) and radiotherapy model of Lewis lung Cancer, we demonstrated that the nanosuit could shield normal cells from IR-induced DNA damage by regulating the molecular biomarkers of anti-apoptosis and anti-oxidative stress. In the accidental total body irradiation (TBI) mice model, the nanosuit pretreated mice exhibited satisfactory alteration of superoxide dismutase (SOD) activities and malondialdehyde (MDA) contents, and functional recovery of hematopoietic system, reducing IR-induced pathological damages of multi-organ and safeguarding mice from lethal radiation. More importantly, the nanosuit showed a selective radioprotection of the normal organs without interferences of tumor control in the radiotherapy model of Lewis lung Cancer. Based on a conveniently available DNA tetrahedron-based nanocarrier, this work presents a high-efficiency delivery system of AMF with the prolonged half-life and enhanced radioprotection for multi-organs. Such nanosuit pioneers a promising strategy with great clinical translation potential for radioactivity protection.

Keywords

Amifostine; DNA damage; Ionizing radiation; Lewis lung cancer model; Multi-organ protection; Nanosuit; Tetrahedral framework nucleic acids.

Figures
Products